333 results on '"Homann N"'
Search Results
2. Risk factors for late post-procedural bleeding after endoscopic resection of large colorectal lesions: a multicenter retrospective study
3. 1472TiP Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early stage, cT1 and cT2N0, esophageal adenocarcinoma: A prospective, multicenter study of the FLOT-AIO Gastric Cancer Group – The IKF-057/ PRESTO trial
4. 1450P Pembrolizumab and olaparib in advanced HER2 negative esophagogastric adenocarcinoma (EGA): Biomarker results of the phase II AIO IKF-038/POLESTAR trial
5. The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer
6. Modelling georeferenced locations of charging infrastructure and electric vehicles based on socio-economic parameters
7. Onkologie II: Grundlagen
8. 1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
9. 1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
10. Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
11. Serumtest für C3a Anaphylatoxin ermöglicht minimal-invasives Screening für kolorektale Tumoren
12. Die intermittierende Impulskompression zur Abschwellung und Thromboseprophylaxe – Pilotstudie nach Hüft-TEP: Ist die Minimalanwendungsdauer von 2 h täglich ausreichend?
13. Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma- Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM
14. Case Report: Simultaneous Detection of Synchronous Colonic and Biliary Carcinoma by Abdominal Ultrasonography in Two Patients with Ulcerative Colitis
15. CASE REPORT: Type I Intestinal Lymphangiectasia Treated Successfully with Slow-Release Octreotide
16. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde
17. Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
18. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression
19. Airlimb Erste Erfahrungen mit einer neuen Sofort-Frühversorgungsprothese mit einzeln ansteuerbaren Luftkammern: Erste Erfahrungen mit einer neuen Sofort-Frühversorgungsprothese mit einzeln ansteuerbaren Luftkammern
20. The post-discectomy syndrome: Aetiology, diagnosis, treatment, prevention
21. p53-Mutationen/ p53-Proteinüberexpression Differentielle Bedeutung für die Progression von Kopf-Hals-Karzinomen*: Differentielle Bedeutung für die Progression von Kopf-Hals-Karzinomen*
22. Serumtest für C3a Anaphylatoxin ermöglicht minimal-invasives Screening für kolorektale Tumoren
23. Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO): V386
24. 1494P Updated safety data of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma - A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK
25. 1443P Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – Safety Results from AIO-STO-0417: A randomized phase II trial of the German Gastric Group of the AIO
26. 1424MO Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma– Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM
27. 1421MO Final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma
28. 1525O The QOLIXANE trial - Real life QoL and efficacy data in 1st line pancreatic cancer from the prospective platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry
29. 5-fluorouracil, leucovorin and oxaliplatin with or without docetaxel in older adult (≥65 years) patients with esophagogastric cancer: FLOT65+ trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO): V412
30. Validation of tumoral matrix-metalloproteinase-9 (MMP-9) mRNA expression as a molecular prognostic factor for metastatic gastroesophageal cancer: V410
31. Pharmacogenetic profiling of peripheral neuropathy in elderly patients (>65years) with advanced gastric cancer receiving oxaliplatin based chemotherapy: V542
32. Manganese Superoxide Dismutase (MnSOD) Polymorphism, Alcohol, Cigarette Smoking and Risk of Oesophageal Cancer
33. Clinical trial: cyclophosphamide pulse therapy – a promising therapeutic alternative in refractory Crohnʼs disease
34. Evaluation vaskulärer Risikofaktoren bei Patienten mit Parkinson-Syndrom
35. Helminths as governors of inflammatory bowel disease
36. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial
37. Prävention der epiduralen Fibrose Erste Erfahrungen mit einer nicht resorbierbaren Membran: Erste Erfahrungen mit einer nicht resorbierbaren Membran
38. Simultaneous Detection of Synchronous Colonic and Biliary Carcinoma by Abdominal Ultrasonography in Two Patients with Ulcerative Colitis
39. Delayed hypersensitivity reactions to diclofenac
40. Type I Intestinal Lymphangiectasia Treated Successfully with Slow-Release Octreotide
41. Increased rectal cell proliferation following alcohol abuse
42. A HOOK SCREW FOR DIRECT REPAIR OF LUMBAR SPONDYLOLYSIS - A MEAN FOLLOW UP OF 11 YEARS
43. Spontaneous orgasms - an epileptic case without structural correlate
44. Ciprofloxacin decreases the rate of ethanol elimination in humans
45. Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO
46. Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK
47. First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying
48. Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers
49. Quality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON
50. Autologous serum eye drops: five years' experience of manufacturing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.